瑞士诺华的地拉罗司最新价格
The chemical name of (deferasirox) is 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid. It is an iron chelator product developed by the Swiss pharmaceutical company Novartis. It is the first oral iron-removing agent approved by the US FDA for routine use. It is approved for use in patients ≥2 years old with chronic iron overload caused by blood transfusion. In Europe, it is recommended as a 6 It is a first-line drug for patients with thalassemia and iron overload over the age of 10. Clinical research is currently underway in China.
Deferasirox is a tridentate iron chelator that combines with ferric ions in a 2:1 ratio to form a complex that is excreted in the feces, thereby reducing iron storage in the body. Due to the continued presence of deferasirox in plasma, plasma non-transferrin-bound iron can be continuously reduced and the iron formed by toxicity in the body can be directly removed.
What is the latest price of Novartis Switzerland? Currently, the most popular drug among patients is deferasirox produced by Novartis, Switzerland. Novartis is a pharmaceutical and biotechnology multinational company headquartered in Basel, Switzerland. Its core businesses are in various patent medicines, consumer healthcare, generic medicines, eye care and animal health. According to Medical Companion Travel, the specification of Deferasirox from Novartis Switzerland is 400mg*30 tablets, but the price is only 420$, which is more suitable for patients for long-term use. Since the exchange rate is not static, the price will also fluctuate. For details, please consult Medical Companion Travel.
Recommended related hot articles: /newsDetail/94104.html
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)